GL1X · GenesisL1 explorer

UniProt Q9WYW0

NAD-dependent protein deacetylase (Q9WYW0)

NAD-dependent protein deacetylase (UniProt Q9WYW0): 32 experimental structures and 1 predicted model on GenesisL1, 1 pocket. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.

UniProt
Q9WYW0
Protein
NAD-dependent protein deacetylase
Experimental structures
32
Predicted models
1
Pockets
1 · 1 record with a druggable one

Structures

33 records of Q9WYW0 in the MolNFT archive: 32 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1YC5Sir2-p53 peptide-nicotinamidex-ray diffractionA——
1YC5SIR2-P53 peptide-nicotinamidex-ray diffractionA——
2H2DThe Structural Basis for Sirtuin Substrate Affinityx-ray diffractionA——
2H2DThe structural basis for sirtuin substrate affinityx-ray diffractionA——
2H2FThe Structural basis for Sirtuin Substrate affinityx-ray diffractionA——
2H2FThe structural basis for sirtuin substrate affinityx-ray diffractionA——
2H2GThe Structural Basis of Sirtuin substrate affinityx-ray diffractionA——
2H2GThe structural basis of sirtuin substrate affinityx-ray diffractionA——
2H2HThe Structural basis of sirtuin substrate specificityx-ray diffractionA——
2H2HThe structural basis of sirtuin substrate specificityx-ray diffractionA——
2H2IThe Structural basis of Sirtuin Substrate Affinityx-ray diffractionA——
2H2IThe structural basis of sirtuin substrate affinityx-ray diffractionA——
2H4FSir2-p53 peptide-NAD+x-ray diffractionA——
2H4FSIR2-P53 peptide-NAD+x-ray diffractionA——
2H4HSir2 H116Y mutant-p53 peptide-NADx-ray diffractionA——
2H4HSIR2 H116Y mutant-P53 peptide-NADx-ray diffractionA——
2H4JSir2-deacetylated peptide (from enzymatic turnover in crystal)x-ray diffractionA——
2H4JSIR2-deacetylated peptide (from enzymatic turnover in crystal)x-ray diffractionA——
2H59Sir2 H116A-deacetylated p53 peptide-3'-o-acetyl ADP ribosex-ray diffractionA, B——
2H59SIR2 H116A-deacetylated P53 peptide-3'-O-acetyl ADP ribosex-ray diffractionA, B——
3D4BCrystal structure of Sir2Tm in complex with Acetyl p53 peptide and DADMe-NAD+x-ray diffractionA——
3D4BCrystal structure of SIR2TM in complex with acetyl P53 peptide and dadme-NAD+x-ray diffractionA——
3D81Sir2-S-alkylamidate complex crystal structurex-ray diffractionA——
3D81SIR2-S-alkylamidate complex crystal structurex-ray diffractionA——
3JR3Sir2 bound to acetylated peptidex-ray diffractionA——
3JR3SIR2 bound to acetylated peptidex-ray diffractionA——
3PDHStructure of Sir2Tm bound to a propionylated peptidex-ray diffractionA——
3PDHStructure of SIR2TM bound to a propionylated peptidex-ray diffractionA——
4BUZSIR2 complex structure mixture of ex-527 inhibitor and reaction products or of reaction substrates…x-ray diffractionA——
4BUZSIR2 complex structure mixture of ex-527 inhibitor and reaction products or of reaction substrates…x-ray diffractionA——
4BV2Crystal structure of SIR2 in complex with the inhibitor ex-527, 2'-O-acetyl-ADP-ribose and…x-ray diffractionA, B——
4BV2Crystal structure of SIR2 in complex with the inhibitor ex-527, 2'-O-acetyl-ADP-ribose and…x-ray diffractionA, B——
Q9WYW0AlphaFold monomer V2.0 prediction for NAD-dependent protein deacetylase (Q9WYW0)predictedA—1 (best 0.75)

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.